Provided by Tiger Trade Technology Pte. Ltd.

iShares U.S. Pharmaceuticals ETF

104.34
-0.3000-0.29%
Post-market: 104.340.00000.00%19:30 EST
Volume:523.61K
Turnover:54.87M
Market Cap:1.66B
PE:9.72
High:106.12
Open:104.90
Low:103.99
Close:104.64
52wk High:112.29
52wk Low:81.45
Shares:15.90M
Float Shares:15.90M
Volume Ratio:2.34
T/O Rate:3.29%
Dividend:1.43
Dividend Rate:1.37%
EPS(TTM):10.74
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

What Bristol Myers Squibb Buyers Were Betting On

Simply Wall St.
·
2 hours ago

Johnson & Johnson (JNJ) Stock Looks Undervalued Based On Future Cash Flow

Simply Wall St.
·
Yesterday

The Bet Merck Holders Made

Simply Wall St.
·
Yesterday

Here's What's Been Proven to Help GLP-1 Users from Losing Too Much Muscle from the Drug

Dow Jones
·
Nov 21

Eli Lilly (LLY) Backed An $87 Million Lyme Disease Vaccine Funding Round

Simply Wall St.
·
Nov 21

How Robot Surgery Launch At JNJ Has Changed Its Investment Story

Simply Wall St.
·
Nov 21

Estee Lauder Cos. Cl a Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Nov 21

Insulet Reappoints Michael R. Minogue to Board

Reuters
·
Nov 21

Stocks Ex-Dividend November 24

Dow Jones
·
Nov 21

Johnson & Johnson Rises After Reporting Positive Arthritis Drug Trial Results

Reuters
·
Nov 21

Eli Lilly Updates Early-Stage LY3839056 Trial: What Investors Should Know

TIPRANKS
·
Nov 21

How Much Merck Do You Really Get Through 3 ETFs?

Simply Wall St.
·
Nov 20

Here's What's Been Proven to Help GLP-1 Users Who Have Lost Muscle from the Drug

Dow Jones
·
Nov 20

Johnson & Johnson's Tremfya Reduces Axial Psoriatic Arthritis Symptoms in Phase 4 Trial

Reuters
·
Nov 20

J&J - Star Study Safety Profile for Tremfya Consistent; no New Safety Signals Identified

THOMSON REUTERS
·
Nov 20

J&J - Tremfya Demonstrates over 2X Greater Reduction in Mri-Assessed Inflammation Versus Placebo at Week 24

THOMSON REUTERS
·
Nov 20

J&J - Tremfya Shows Statistically Significant Improvement in Basdai Score Versus Placebo in Phase 4 Study

THOMSON REUTERS
·
Nov 20

J&J - Reports Tremfya Demonstrates Mri-Confirmed Improvements in Spinal Pain and Stiffness

THOMSON REUTERS
·
Nov 20

Analysts Conflicted on These Consumer Goods Names: Wal-Mart de Mexico SAB de CV (OtherWMMVF), J & J Snack Foods (JJSF) and Target (TGT)

TIPRANKS
·
Nov 20

Analysts Are Bullish on Top Healthcare Stocks: Solid Biosciences (SLDB), Eli Lilly & Co (LLY)

TIPRANKS
·
Nov 20